ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Nicholas Piramal India, The Ahmedabad Electricity Company, Finolex Industries

NICHOLAS PIRAMAL INDIA Building on Research Nicholas Piramal India with its strong emphasis on the domestic pharmaceutical market, achieved sales growth of 20 per cent in 2002-03, against a domestic industry growth rate of 8-9 per cent. With total sales of Rs 1,136 crore, net profit was more than doubled to Rs 118 crore. With 21 new products being launched during the year, the number of new products over the last two years rises to 35. The company has also reduced its interest costs by repaying a portion of its debt and substituting the rest with low cost debt. Net interest outgo came down by 34 per cent to Rs 20.58 crore.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top